Dataset Information

PVRL2 suppresses anti-tumor immunity through PVRIG- and TIGIT-independent pathways

ABSTRACT: Here, we share discovery proteomics data associated with a larger study to expose new immunoregulatory mechanisms in cancer. PVRL2 was identified in both tumor cells and exosomes, and the role of this surface protein in the immune response to cancer was explored in further studies.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Primary Cell, Cell Culture

SUBMITTER: James Byrnes

LAB HEAD: James Wells

PROVIDER: PXD044245 | Pride | 2024-05-21

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	200723_TRAMP_200ng_JRB_Slot1-25_1_139.d.7z	Other
	200917_TRAMP_EXO_200ng_Slot2-33_1_331.d.7z	Other
	200917_TRAMP_INF_EXO_1_200ng_Slot2-31_1_329.d.7z	Other
	200917_TRAMP_INF_EXO_2_200ng_Slot2-32_1_330.d.7z	Other
	Data_Legend.xlsx	Xlsx

Items per page:

1 - 5 of 27

Publications

PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.

Yang Jiuling J Wang Li L Byrnes James R JR Kirkemo Lisa L LL Driks Hannah H Belair Cassandra D CD Aguilar Oscar A OA Lanier Lewis L LL Wells James A JA Fong Lawrence L Blelloch Robert R

Cancer immunology research 20240501 5

Poliovirus receptor-related 2 (PVRL2, also known as nectin-2 or CD112) is believed to act as an immune checkpoint protein in cancer; however, most insight into its role is inferred from studies on its known receptor, poliovirus receptor (PVR)-related immunoglobulin domain protein (PVRIG, also known as CD112R). Here, we study PVRL2 itself. PVRL2 levels were found to be high in tumor cells and tumor-derived exosomes. Deletion of PVRL2 in multiple syngeneic mouse models of cancer showed a dramatic ...[more]

PMID: 38588410

Similar Datasets

Project description:Background: Docosahexaenoic acid (DHA) is a natural compound with anticancer and anti-angiogenesis activity that is currently under investigation as both a preventative agent and an adjuvant to breast cancer therapy. However, the precise mechanisms of DHA’s anticancer activities are unclear. It is understood that the intercommunication between cancer cells and their microenvironment is essential to tumor angiogenesis. Exosomes are extracellular vesicles that are important mediators of intercellular communication and play a role in promoting angiogenesis. However, very little is known about the contribution of breast cancer exosomes to tumor angiogenesis or whether exosomes can mediate DHA’s anticancer action. Results: Exosomes were collected from MCF7 and MDA-MB-231 breast cancer cells after treatment with DHA. We observed an increase in exosome secretion and exosome microRNA contents from the DHA-treated cells. The expression of 83 microRNAs in the MCF7 exosomes was altered by DHA (>2-fold). The most abundant exosome microRNAs (let-7a, miR-23b, miR-27a/b, miR-21, let-7, and miR-320b) are known to have anti-cancer and/or anti-angiogenic activity. These microRNAs were also increased by DHA treatment in the exosomes from other breast cancer lines (MDA-MB-231, ZR751 and BT20), but not in exosomes from normal breast cells (MCF10A). When DHA-treated MCF7 cells were co-cultured with or their exosomes were directly applied to endothelial cell cultures, we observed an increase in the expression of these microRNAs in the endothelial cells. Furthermore, overexpression of miR-23b and miR-320b in endothelial cells decreased the expression of their pro-angiogenic target genes (PLAU, AMOTL1, NRP1 and ETS2) and significantly inhibited tube formation by endothelial cells, suggesting that the microRNAs transferred by exosomes mediate DHA’s anti-angiogenic action. These effects could be reversed by knockdown of the Rab GTPase, Rab27A, which controls exosome release. Conclusions: We conclude that DHA alters breast cancer exosome secretion and microRNA contents, which leads to the inhibition of angiogenesis. Our data demonstrate that breast cancer exosome signaling can be targeted to inhibit tumor angiogenesis and provide new insight into DHA’s anticancer action, further supporting its use in cancer therapy. Examination of small RNA populations in MCF7 cells and exosomes after DHA treatment.